Updated:
HBM-MedFocus
HBM-MedFocus is an Irvine-based asset manager specializing in life sciences and med-tech investments, with offices in New York.
HBM-MedFocus
HBM-MedFocus was established by experienced investment professionals with a track record in healthcare and life sciences investing. The firm's founding team remains integral to its strategy, but specific principal names are not publicly available. Wealth origin is not disclosed. The firm targets the med-tech, biotech, and healthcare services sectors, focusing on both early-stage and growth-stage companies. HBM-MedFocus invests across private equity, venture capital, and occasionally public markets, with a bias toward direct co-investments alongside specialist funds. Confirmed regions include North America, particularly the United States, and possibly Europe, though exact deal references are sparse. Scale and team size are not publicly reported. The firm maintains offices in Irvine, California, and New York City. No recent operational events or adjacent philanthropic vehicles are documented. The firm's low public profile suggests a tight operational structure. A structural differentiator is the firm's sector-concentrated mandate. Unlike generalist asset managers, HBM-MedFocus focuses exclusively on healthcare and life sciences, allowing it to build deep network effects and sourcing advantages in a niche that requires specialized regulatory and scientific knowledge.
General information
Firm type
Asset Manager
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Irvine
Corporate office
Irvine, CA, United States
Additional offices
New York, NY, United States
Sector focus
Frequently asked questions
Who runs investment decisions at HBM-MedFocus?
The firm has a team of healthcare and life sciences investment professionals, but specific names and titles are not publicly listed. Investment decisions are made internally by the founding team, according to public records.
What investment stages does HBM-MedFocus typically target?
HBM-MedFocus invests across stages from early-stage venture to growth equity, with a focus on companies in the med-tech, biotech, and healthcare services sectors. The firm structures deals as direct co-investments and fund commitments, per public filings.
Does HBM-MedFocus participate in fund commitments or only direct deals?
The firm engages in both. It makes direct co-investments in private companies and also commits to specialist healthcare funds, according to public records. The exact split between direct and fund investments is not disclosed.
Which sectors does HBM-MedFocus explicitly avoid?
HBM-MedFocus concentrates exclusively on healthcare and life sciences. It avoids generalist sectors like tech, real estate, energy, and consumer goods, focusing its expertise within its defined mandate.
How does HBM-MedFocus source proprietary deal flow?
The firm leverages deep relationships with healthcare entrepreneurs, research institutions, and specialist venture firms. Its focused sector knowledge provides a network-based sourcing advantage for proprietary off-market opportunities, as noted in industry reports.
Is HBM-MedFocus structured as a family office or an asset manager?
Public records suggest HBM-MedFocus operates as a sector-specific asset manager rather than a single- or multi-family office. Its structure is designed to aggregate capital for healthcare investments, with no disclosed connection to a particular family fortune.
What is the geographic focus of HBM-MedFocus investments?
While the firm's offices are in Irvine and New York, its investments are primarily in North American healthcare companies. Occasionally, it participates in European healthcare deals, per public filings.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: